Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KAWADA T
    Dairy intake and prostate cancer survival.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30703.
    PubMed     Text format    


    February 2017
  2. DOWNER MK, Batista JL, Mucci LA, Stampfer MJ, et al
    Dairy intake in relation to prostate cancer survival.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30642.
    PubMed     Text format     Abstract available


    January 2017
  3. SHEN J, Li Z, Song Z, Chen J, et al
    Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30622.
    PubMed     Text format     Abstract available


  4. HORI S, Wadhwa K, Pisupati V, Zecchini V, et al
    Loss of hSef promotes metastasis through up-regulation of EMT in prostate cancer.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30604.
    PubMed     Text format     Abstract available


    December 2016
  5. FARRIS MS, Kopciuk KA, Courneya KS, McGregor SE, et al
    Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30586.
    PubMed     Text format     Abstract available


    November 2016
  6. KUNUTSOR SK, Laukkanen JA
    Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30511.
    PubMed     Text format     Abstract available


    October 2016
  7. HAGGSTROM C, Van Hemelrijck M, Zethelius B, Robinson D, et al
    Prospective study of Type 2 Diabetes Mellitus, anti-diabetic drugs, and risk of prostate cancer.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30480.
    PubMed     Text format     Abstract available


  8. TAYLOR AE, Martin RM, Geybels MS, Stanford JL, et al
    Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30462.
    PubMed     Text format     Abstract available


  9. NAIR-SHALLIKER V, Yap S, Nunez C, Egger S, et al
    Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Cancer Lifestyle and Evaluation of Risk Study (CLEAR).
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30471.
    PubMed     Text format     Abstract available


    September 2016
  10. BRUNNER C, Davies NM, Martin RM, Eeles R, et al
    Alcohol Consumption and Prostate Cancer Incidence and Progression: A Mendelian Randomization Study.
    Int J Cancer. 2016 Sep 19. doi: 10.1002/ijc.30436.
    PubMed     Text format     Abstract available


  11. WILSON KM, Markt SC, Fang F, Nordenvall C, et al
    Snus use, smoking and survival among prostate cancer patients.
    Int J Cancer. 2016 Sep 1. doi: 10.1002/ijc.30411.
    PubMed     Text format     Abstract available


    August 2016
  12. CRAWLEY D, Garmo H, Rudman S, Stattin P, et al
    Association between duration and type of Androgen Deprivation Therapy and risk of diabetes in men with prostate cancer.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30403.
    PubMed     Text format     Abstract available


    June 2016
  13. RAMBERG H, Grytli HH, Nygard S, Wang W, et al
    PBX3 is a putative biomarker of aggressive Prostate Cancer.
    Int J Cancer. 2016 Jun 7. doi: 10.1002/ijc.30220.
    PubMed     Text format     Abstract available


    May 2016
  14. ZUCCHETTO A, Gini A, Shivappa N, Hebert JR, et al
    Dietary inflammatory index and prostate cancer survival.
    Int J Cancer. 2016 May 31. doi: 10.1002/ijc.30208.
    PubMed     Text format     Abstract available


  15. BONILLA C, Lewis SJ, Rowlands MA, Gaunt TR, et al
    Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30206.
    PubMed     Text format     Abstract available


  16. THAMILSELVAN V, Menon M, Thamilselvan S
    Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants and Akt in preclinical models: New hope for patients with prostate cancer.
    Int J Cancer. 2016 May 20. doi: 10.1002/ijc.30189.
    PubMed     Text format     Abstract available


    April 2016
  17. KENDEL F, Helbig L, Neumann K, Herden J, et al
    Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
    Int J Cancer. 2016 Apr 2. doi: 10.1002/ijc.30123.
    PubMed     Text format     Abstract available


    March 2016
  18. BURDELSKI C, Kleinhans S, Kluth M, Hube-Magg C, et al
    Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
    Int J Cancer. 2016;138:1199-206.
    PubMed     Text format     Abstract available


    February 2016
  19. LAPI F, Levi M, Simonetti M, Cancian M, et al
    Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30061.
    PubMed     Text format     Abstract available


  20. BONN SE, Sjolander A, Tillander A, Wiklund F, et al
    Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
    Int J Cancer. 2016 Feb 23. doi: 10.1002/ijc.30052.
    PubMed     Text format     Abstract available


  21. YU L, Toriseva M, Tuomala M, Seikkula H, et al
    Increased expression of fibroblast growth factor 13 (FGF13) in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
    Int J Cancer. 2016 Feb 17. doi: 10.1002/ijc.30048.
    PubMed     Text format     Abstract available


  22. RYBICKI BA, Rundle A, Kryvenko ON, Mitrache N, et al
    Methylation in Benign Prostate and Risk of Disease Progression in Men Subsequently Diagnosed with Prostate Cancer.
    Int J Cancer. 2016 Feb 10. doi: 10.1002/ijc.30038.
    PubMed     Text format     Abstract available


  23. WANG Y, Jacobs EJ, Newton CC, McCullough ML, et al
    Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study-II Nutrition Cohort.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30027.
    PubMed     Text format     Abstract available


    January 2016
  24. MURTOLA TJ, Karppa EK, Taari K, Talala K, et al
    5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30017.
    PubMed     Text format     Abstract available


  25. SUDHAN DR, Pampo C, Rice L, Siemann DW, et al
    Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29992.
    PubMed     Text format     Abstract available


    December 2015
  26. DYSHLOVOY SA, Menchinskaya ES, Venz S, Rast S, et al
    The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29977.
    PubMed     Text format     Abstract available


  27. DE CARVALHO TM, Heijnsdijk EA, de Koning HJ
    Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29976.
    PubMed     Text format     Abstract available


  28. WU K, Spiegelman D, Hou T, Albanes D, et al
    Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29973.
    PubMed     Text format     Abstract available


  29. THOMSEN FB, Folkvaljon Y, Garmo H, Robinson D, et al
    Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.
    Int J Cancer. 2015 Dec 14. doi: 10.1002/ijc.29961.
    PubMed     Text format     Abstract available


  30. LYNCH HT, Kosoko-Lasaki O, Leslie SW, Rendell M, et al
    Screening for Familial and Hereditary Prostate Cancer.
    Int J Cancer. 2015 Dec 5. doi: 10.1002/ijc.29949.
    PubMed     Text format     Abstract available


    November 2015
  31. CASTRO NAVA A, Cojoc M, Peitzsch C, Cirillo G, et al
    Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.
    Int J Cancer. 2015;137:2492-503.
    PubMed     Text format     Abstract available


    October 2015
  32. KE ZHOU C, Check DP, Lortet-Tieulent J, Laversanne M, et al
    Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.
    Int J Cancer. 2015 Oct 21. doi: 10.1002/ijc.29894.
    PubMed     Text format     Abstract available


  33. PAPANTONIOU K, Castano-Vinyals G, Llorca J, Pollan M, et al
    Authors' response to Letter to the Editor.
    Int J Cancer. 2015;137:1786-7.
    PubMed     Text format    


    September 2015
  34. CHEN Q, Chen T, Shi W, Zhang T, et al
    Adult Weight Gain and Risk of Prostate Cancer: A Dose-response Meta-analysis of Observational Studies.
    Int J Cancer. 2015 Sep 10. doi: 10.1002/ijc.29846.
    PubMed     Text format     Abstract available


  35. MOLLER E, Wilson KM, Batista JL, Mucci LA, et al
    Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.
    Int J Cancer. 2015 Sep 10. doi: 10.1002/ijc.29842.
    PubMed     Text format     Abstract available


    August 2015
  36. RANDAZZO M, Beatrice J, Huber A, Grobholz R, et al
    Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau).
    Int J Cancer. 2015;137:553-9.
    PubMed     Text format     Abstract available


    July 2015
  37. CHEN C, Cai Q, He W, Li Z, et al
    An NKX3.1 Binding Site Polymorphism in the L-plastin Promoter Leads to Differential Gene Expression in Human Prostate Cancer.
    Int J Cancer. 2015 Jul 6. doi: 10.1002/ijc.29677.
    PubMed     Text format     Abstract available


  38. DUIJVESZ D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, et al
    Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29664.
    PubMed     Text format     Abstract available


  39. GANSMO LB, Knappskog S, Romundstad P, Hveem K, et al
    Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.
    Int J Cancer. 2015;137:96-103.
    PubMed     Text format     Abstract available


    June 2015
  40. LODHIA KA, Gao S, Aleksic T, Esashi F, et al
    Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
    Int J Cancer. 2015;136:2961-6.
    PubMed     Text format     Abstract available


    May 2015
  41. KLUTH M, Runte F, Barow P, Omari J, et al
    Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.
    Int J Cancer. 2015 May 22. doi: 10.1002/ijc.29613.
    PubMed     Text format     Abstract available


  42. YANG M, Kenfield SA, Van Blarigan EL, Wilson KM, et al
    Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29608.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: